From the Abstract: "We analyze the effectiveness of preventive investments aimed at increasing agents' life expectancy, with a focus on influenza and COVID-19 [coronavirus disease 2019] mitigation. Maximizing overall life expectancy requires allocating resources across hazards so as to equalize investments' marginal effectiveness. Based on estimates for the marginal effectiveness of influenza vaccines, we determine the level of COVID-19 mitigation investments that would imply such equalization. Given current projections for COVID-19 mitigation costs, our results suggest that wide-spread influenza vaccination would be an effective life-preserving investment."
NBER Working Paper No. 27382; National Bureau of Economic Research Working Paper No. 27382
2020 Jules H. van Binsbergen and Christian C. Opp
National Bureau of Economic Research: https://www.nber.org/